Skip to main content
Terug
Watch Compare

Incannex Healthcare Inc.

Datakwaliteit: 100%
IXHL
Nasdaq Manufacturing Chemicals
€ 3,12
▲ € 0,24 (8,33%)
Marktkapitalisatie: 39,82 M
Prijs
€ 2,85
Marktkapitalisatie
39,82 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -20,34 M
Capital intensive — 268,37% of revenue goes to capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-38,17%
Boven sectorgemiddelde (-53,34%)
ROIC-28,25%
Net Margin-29288,78%
Op. Margin-27467,35%

Veiligheid

Debt / Equity
N/A
Current Ratio48,27
Interest CoverageN/A

Waardering

PE (TTM|2027)
-1,39 | 2,26
Boven sectorgemiddelde (-1,47)
P/B Ratio0,54
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,4 -1,5
P/B 0,5 1,6
ROE % -38,2 -53,3
Net Margin % -29288,8 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 1,26
€ 1,26 – € 1,26
 56,59 M 1
FY2026 -€ 1,71
-€ 1,71 – -€ 1,71
 0,0 1

Winstverassingen

Laatste 6 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,93 -€ 0,85 +8,7%
Q32025 -€ 18,09 -€ 0,92 +94,9%
Q22025 -€ 13,47 -€ 23,26 -72,7%
Q12025 -€ 21,72 -€ 9,38 +56,8%
2026-Q2 -€ 0,84 -€ 0,02 +97,6%
2026-Q1 -€ 0,84 -€ 0,02 +97,6%

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
1,28% weight
BRSIX BRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 98.000,0 Net Income (TTM) -28,70 M
ROE -38,17% ROA -37,34%
Gross Margin N/A Operating Margin -27467,35%
Net Margin -29288,78% Free Cash Flow (TTM) -20,34 M
ROIC -28,25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 48,27
Interest Coverage N/A Asset Turnover 0,00
Working Capital 73,13 M Tangible Book Value 73,41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,39 Forward P/E N/A
P/B Ratio 0,54 P/S Ratio 406,38
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51,08%
Market Cap 39,82 M Enterprise Value -29,08 M
Per Share
EPS (Diluted TTM) -0,89 Revenue / Share 0,01
FCF / Share -1,46 OCF / Share -1,47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 268,37% FCF Conversion 70,87%
SBC-Adj. FCF -27,78 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2025 FY2022
Revenue 12.000,0 — —
Net Income -18,46 M -46,89 M —
EPS (Diluted) -1,15 -1,35 —
Gross Profit — — —
Operating Income -30,04 M -23,79 M —
EBITDA — — —
R&D Expenses 12,88 M 10,75 M —
SG&A Expenses — — —
D&A 103.000,0 246.000,0 —
Interest Expense — 303.000,0 —
Income Tax 30.000,0 30.000,0 —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2025
Total Assets 17,05 M 20,45 M
Total Liabilities 5,83 M 7,06 M
Shareholders' Equity 11,22 M 13,39 M
Total Debt — —
Cash & Equivalents 5,86 M 15,04 M
Current Assets 16,20 M 19,96 M
Current Liabilities 5,62 M 6,98 M